Yang Huai-Che, Lin Chung-Jung, Luo Chao-Bao, Lee Cheng-Chia, Wu Hsiu-Mei, Guo Wan-Yuo, Chung Wen-Yuh, Liu Kang-Du
Neurologic Institute, Department of Neurosurgery, Taipei Veterans General Hospital, 201 Shipai Rd, Sec 2, Beitou District, 112, Taipei, Taiwan, ROC.
School of Medicine, National Yang Ming University, Taipei, Taiwan, ROC.
Clin Neuroradiol. 2020 Jun;30(2):321-330. doi: 10.1007/s00062-019-00787-z. Epub 2019 May 16.
Endovascular treatment (EVT) and stereotaxic gamma-knife radiosurgery (GKRS) can both effectively treat cavernous sinus dural arteriovenous fistulas (CSDAVF). This study compared the prognostic factors and treatment effectiveness of GKRS and EVT for different CSDAVF types.
The charts of 200 patients undergoing GKRS and 105 patients undergoing EVT were reviewed for data on symptoms (e.g. orbital, cavernous, ocular, and cerebral). The CSDAVFs were classified into proliferative, restrictive, and late restrictive types. The prognostic factors for complete obliteration (CO) were evaluated in both the GKRS and EVT groups and the latent period to CO was measured. For statistical analysis χ-tests were used to compare final CO rates for EVT and GKRS across the three CSDAVF types.
The EVT and cavernous symptoms were significant independent predictors of CO. The CO rate after EVT (97.9%) was significantly higher than that after GKRS (63.5%) for restrictive CSDAVFs (P < 0.001) but not for proliferative or late restrictive types. In the GKRS group, cavernous symptoms (hazard ratio, HR: 0.557) and target volume (HR: 0.853) predicted CO, but only target volume remained significant in multivariate analysis. In the EVT group, the latent period to CO was shortest for restrictive CSDAVFs (3.2 ± 1.6 months, P = 0.05).
Angioarchitecture did not affect treatment outcomes. Cavernous symptoms were strongly associated with lower complete obliteration rates in the GKRS but not the EVT group. The EVT method remains the treatment of choice, especially for restrictive CSDAVFs; however, compared to EVT, GKRS had lower complication rates and similar therapeutic effects for proliferative type fistulas.
血管内治疗(EVT)和立体定向伽玛刀放射外科治疗(GKRS)均可有效治疗海绵窦硬脑膜动静脉瘘(CSDAVF)。本研究比较了GKRS和EVT治疗不同类型CSDAVF的预后因素及治疗效果。
回顾了200例行GKRS治疗的患者和105例行EVT治疗的患者的病历,以获取症状(如眼眶、海绵窦、眼部和脑部症状)数据。将CSDAVF分为增殖型、限制型和晚期限制型。评估GKRS组和EVT组完全闭塞(CO)的预后因素,并测量达到CO的潜伏期。采用χ检验进行统计分析,比较EVT和GKRS在三种CSDAVF类型中的最终CO率。
EVT和海绵窦症状是CO的显著独立预测因素。对于限制型CSDAVF,EVT后的CO率(97.9%)显著高于GKRS后的CO率(63.5%)(P<0.001),但对于增殖型或晚期限制型则不然。在GKRS组中,海绵窦症状(风险比,HR:0.557)和靶体积(HR:0.853)可预测CO,但在多因素分析中只有靶体积仍具有显著性。在EVT组中,限制型CSDAVF达到CO的潜伏期最短(3.2±1.6个月,P=0.05)。
血管构筑不影响治疗结果。海绵窦症状与GKRS组较低的完全闭塞率密切相关,但与EVT组无关。EVT方法仍是首选治疗方法,尤其是对于限制型CSDAVF;然而,与EVT相比,GKRS治疗增殖型瘘的并发症发生率较低且治疗效果相似。